Statistics for Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models
Total visits
views | |
---|---|
Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models | 4 |
Total visits per month
views | |
---|---|
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 2 |
July 2025 | 0 |
August 2025 | 0 |
September 2025 | 1 |
October 2025 | 1 |
File Visits
views | |
---|---|
tcr-14-03-1531.pdf | 3 |